Skip to content
DataLookout
Menu

NCT04063514

The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier

StatusWithdrawn
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial status changed: Enrolling by Invitation → Withdrawn Sponsor's reason: Insufficient resources Show 5 more changesShow less
    • Enrollment target: estimated 15 to confirmed 0
    • Primary endpoints: details revised at 1 of 2 entries
    • Eligibility criteria expanded, about 2 words
    • Start date: Jun 11, 2021 to Jun 11, 2018
    • Publications: details revised at 11 of 11 entries
  2. Minor Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    v7
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 21, 2025 to Jun 11, 2021
    • Site details revised
    v6
  4. Minor Interventions: Focused Ultrasound and Microbubble Infusion (Other) to Focused Ultrasound (Other)
    • Study description shortened, about 24 words
    • Study title shortened, about 1 word
    v5
  5. Notable Primary completion date: Apr 18, 2021 to Apr 18, 2026
    • Start date: Feb 21, 2020 to Feb 21, 2025
    • Study completion date: Jan 20, 2022 to Jan 20, 2027
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Primary completion date: Apr 18, 2020 to Apr 18, 2021
    • Start date: Sep 21, 2019 to Feb 21, 2020
    • Study completion date: Jan 20, 2021 to Jan 20, 2022
    v3
  2. Notable Primary endpoints revised (2)v2
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Adverse Event (AE) & Serious Adverse Event (SAE) Reporting
Timeframe: 24 hours
functional Magnetic Resonance Imaging (fMRI)
Timeframe: 3 hours

Arms and interventions

Focused UltrasoundExperimental

The ultrasound treatment will last either 1 hour or 20 minutes total time for the DWL device or Brainsonix Focused Ultrasound Device, respectively.

Other: Focused Ultrasound

Sites

1 site in 1 country

  • Neurological Associates of West LASanta Monica, California, United States